Skip to content

OXINIUM 71342364Recalls & reported problems

Smith & Nephew, Inc. · OXINIUM FEMORAL HEAD 14/16 TAPER 36MM +4 NECK · Class 2 · Implant

All models of OXINIUM (36)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 03596010502278), received between Jun 10, 2022 and Jun 10, 2022 — classified as 1 injury.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Use of Device Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 10, 2022Use of Device Problem; Use of Device Problem

    IT WAS REPORTED THAT, DURING A THA SURGERY PERFORMED ON (B)(6) 2022, A OXINIUM FEMORAL HEAD 14/16 TAPER 36MM +4 NECK WAS IMPLANTED BY MISTAKE, AS IT WAS NOT NOTICED THAT IT WAS THE INCORRECT SIZE. PATIENT UNDERWENT A REVISION SURGERY ON (B)(6) 2022 TO REPLACE THE OXINIUM FEMORAL HEAD 14/16 TAPER 36MM +4 NECK WITH THE APPROPRIATE 12/14 TAPER OXINIUM HEAD. PATIENT DID NOT REPORT ANY SYMPTOMS PRIOR TO THE REVISION. PATIENT IS RECOVERING FROM SURGERY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14655113 ↗

Other Prosthesis, hip, semi-constrained, metal/polymer, cemented devices

All Prosthesis, hip, semi-constrained, metal/polymer, cemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page